A recent survey by the Kaiser Family Foundation (KFF) reveals that less than half of Americans trust President Donald Trump or Robert F. Kennedy Jr. to lead the nation effectively on health issues. The findings come as the Trump administration faces scrutiny over its health policy appointments, including Dr. Mehmet Oz and Kennedy, both of whom are central figures in the president’s healthcare strategy.
According to the survey, only 42% of respondents said they have at least “a fair amount of trust” in Trump to make sound recommendations on health-related matters. This level of trust is mirrored for Kennedy, who has been nominated to lead the Department of Health and Human Services (HHS), and Dr. Mehmet Oz, Trump’s pick to lead the Centers for Medicare and Medicaid Services (CMS). Both appointments have drawn widespread criticism, with concerns raised about their qualifications and positions on key health issues.
Robert F. Kennedy Jr., a controversial figure due to his outspoken skepticism about vaccines, has faced bipartisan criticism ahead of his Senate confirmation hearings. Despite his family legacy and advocacy for environmental and public health issues, his positions on vaccines and health policy have sparked fierce debate. Democrats and some Republicans worry that his appointment could undermine public health initiatives, especially as the nation grapples with ongoing challenges like vaccine uptake and pandemic preparedness.
Dr. Mehmet Oz, a celebrity physician known for his television career, has also come under fire for his medical recommendations, which critics argue lack scientific rigor. His nomination to lead CMS, a pivotal agency overseeing Medicare and Medicaid, has raised questions about his ability to manage such a complex and essential institution.
The low trust ratings reflect broader skepticism about the Trump administration’s handling of health issues. Since returning to office, Trump has doubled down on his America First healthcare agenda, focusing on reducing healthcare costs, expanding access to private insurance options, and revamping Medicare and Medicaid. However, critics argue that his policies lack comprehensive solutions for systemic issues, such as hospital understaffing, drug pricing transparency, and healthcare access for underserved communities.
Kennedy’s confirmation hearings, set to take place this week, are expected to be contentious. Senators are likely to question his stance on vaccines, his views on pandemic response strategies, and his broader approach to public health. Some lawmakers have already signaled their opposition, citing concerns about his alignment with evidence-based health practices.
Public trust in the administration’s health leadership is a pressing concern as the nation faces several health crises, including the ongoing opioid epidemic, healthcare worker shortages, and rising healthcare costs. Advocacy groups and public health experts warn that the administration’s appointments could further erode public confidence in federal health agencies.
Despite the criticism, the White House defends its nominees, with Press Secretary Karoline Leavitt stating that both Kennedy and Oz bring “fresh perspectives and bold leadership” to the table. Leavitt emphasized the administration’s commitment to addressing America’s healthcare challenges and called for bipartisan cooperation to achieve meaningful reform.
The survey highlights the polarized nature of public opinion on health leadership. While Trump and his nominees maintain strong support among their base, significant portions of the population remain skeptical of their ability to navigate the complexities of the healthcare system. As confirmation hearings unfold and health policies take shape, the administration faces mounting pressure to demonstrate competence and earn the trust of the American people.
